vTv Therapeutics Inc.

NASDAQ: VTVT · Real-Time Price · USD
15.46
1.43 (10.19%)
At close: Aug 15, 2025, 3:58 PM
15.73
1.75%
After-hours: Aug 15, 2025, 04:10 PM EDT

vTv Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
25.92M 31.06M 36.75M 41.57M 45.53M 52.26M 9.45M 8.24M 12.6M 18.77M 12.13M 15.34M 17.86M 12.14M 13.41M 19.57M 10.84M 8.45M
Short-Term Investments
n/a n/a 85K 85K 65K 65K 65K n/a 15K 15K 15K 15K 85K 30K 100K 103K 124K 60K
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a 4.39M 8.03M 7.69M 5.59M 6.17M 5.77M 5.94M 9.17M 8.54M 9.62M 6.72M
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a -8.2M -6.14M -6.73M -6.38M n/a n/a n/a n/a n/a
Receivables
n/a n/a 62K 242K 306K 981K 102K n/a n/a n/a 12.42M 12.15M 12.02M 57K 57K 928K n/a 2K
Inventory
n/a n/a n/a n/a -65K n/a n/a n/a n/a n/a 15K 15K 85K 30K 100K 103K n/a 60K
Other Current Assets
452K 115K 85K 1.06M 368K 571K n/a 1.87M 1.32M 1.85M n/a 1.28M 643K 1.39M 135K 1.57M 313K 710K
Total Current Assets
26.37M 31.92M 38.11M 42.96M 46.2M 53.87M 10.66M 10.13M 13.94M 20.63M 27.09M 28.78M 30.61M 13.61M 15.62M 22.17M 11.27M 9.22M
Property-Plant & Equipment
74K 111K 153K 206K 258K 311K 361K 412K 461K 509K 556K 558K 608K 634K 680K 724K 766K 808K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
74K 111K 153K 206K 258K 311K 361K 4.8M 8.49M 8.2M 6.14M 6.73M 6.38M 6.57M 9.85M 9.26M 10.39M 7.53M
Total Assets
26.45M 32.03M 38.27M 43.16M 46.46M 54.18M 11.02M 14.92M 22.43M 28.83M 33.24M 35.52M 36.99M 20.18M 25.47M 31.43M 21.66M 16.75M
Account Payables
n/a 4.19M 939K 6.23M 6.79M 8.73M 4.08M -17K -17K 8.36M 2.46M 6.68M 9.6M 12.47M 1.88M 4.66M 4.86M 4.96M
Deferred Revenue
n/a n/a n/a 17K 17K 17K 17K 17K 17K 17K 17K 26K 26K 35K 35K 35K 35K 35K
Short-Term Debt
79K n/a n/a n/a n/a 173K 191K 473K 161K n/a 378K 765K 199K 191K 440K 812K 169K 162K
Other Current Liabilities
5.22M n/a n/a n/a n/a -173K n/a n/a 8.96M n/a 3.91M -208K -199K -191K 6.04M -176K -169K -162K
Total Current Liabilities
5.29M 4.32M 5.2M 6.42M 6.99M 8.92M 10.62M 10.28M 9.29M 8.53M 7.71M 7.47M 9.82M 12.7M 8.5M 5.51M 5.06M 5.16M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
18.75M 145K 100K 18.8M 18.96M 19.15M 110K 18.95M 19.29M 19.59M 684K 20.08M 19.39M 770K 1.26M 2.31M 3.64M 4.57M
Total Long-Term Liabilities
18.75M 18.81M 18.77M 18.83M 19.04M 19.27M 18.95M 19.16M 19.54M 39.49M 36.27M 44.62M 35.69M 15.58M 26.72M 47.47M 64.42M 67.87M
Total Liabilities
24.04M 23.13M 23.96M 25.25M 26.02M 28.2M 29.57M 29.43M 28.83M 48.02M 43.98M 52.09M 45.52M 28.28M 35.21M 52.98M 69.48M 73.03M
Total Debt
79K 125K 169K 213K 256K 298K 529K 851K 417K 454K 716K 1.1M 587K 632K 932K 1.35M 756K 795K
Common Stock
32K 32K 32K 32K 30K 30K 27K 1.05M 1.05M 1.05M 1.05M 1.05M 1M 901K 901K 897K 834K 808K
Retained Earnings
-310.86M -304.81M -299.72M -296.08M -291.3M -286.12M -281.04M -281.19M -280.81M -274.32M -265.52M -267.06M -253.3M -247.66M -248.83M -259M -273.11M -274.73M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4M n/a n/a n/a 0.00 n/a n/a
Shareholders Equity
2.76M 7.92M 12.2M 15.01M 16.48M 20.8M -24.68M -25.23M -25.28M -19.19M -10.74M -16.57M -8.53M -8.09M -9.74M -21.55M -47.82M -56.27M
Total Investments
n/a n/a 85K 85K 65K 65K 65K 4.39M 8.03M 7.69M 5.59M 6.17M 5.77M 5.94M 9.17M 8.54M 9.62M 6.72M